The Role of Iron and Zinc in the Treatment of ADHD among Children and Adolescents: A Systematic Review of Randomized Clinical Trials

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder common from childhood to adulthood, affecting 5% to 12% among the general population in developed countries. Potential etiological factors have been identified, including genetic causes, environmental elements and epige...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Roser Granero, Alfred Pardo-Garrido, Ivonne Lorena Carpio-Toro, Andrés Alexis Ramírez-Coronel, Pedro Carlos Martínez-Suárez, Geovanny Genaro Reivan-Ortiz
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/b888a072aa5e422a8f50aacf88d99d81
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b888a072aa5e422a8f50aacf88d99d81
record_format dspace
spelling oai:doaj.org-article:b888a072aa5e422a8f50aacf88d99d812021-11-25T18:36:27ZThe Role of Iron and Zinc in the Treatment of ADHD among Children and Adolescents: A Systematic Review of Randomized Clinical Trials10.3390/nu131140592072-6643https://doaj.org/article/b888a072aa5e422a8f50aacf88d99d812021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6643/13/11/4059https://doaj.org/toc/2072-6643Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder common from childhood to adulthood, affecting 5% to 12% among the general population in developed countries. Potential etiological factors have been identified, including genetic causes, environmental elements and epigenetic components. Nutrition is currently considered an influencing factor, and several studies have explored the contribution of restriction and dietary supplements in ADHD treatments. Iron is an essential cofactor required for a number of functions, such as transport of oxygen, immune function, cellular respiration, neurotransmitter metabolism (dopamine production), and DNA synthesis. Zinc is also an essential trace element, required for cellular functions related to the metabolism of neurotransmitters, melatonin, and prostaglandins. Epidemiological studies have found that iron and zinc deficiencies are common nutritional deficits worldwide, with important roles on neurologic functions (poor memory, inattentiveness, and impulsiveness), finicky appetite, and mood changes (sadness and irritability). Altered levels of iron and zinc have been related with the aggravation and progression of ADHD. Objective: This is a systematic review focused on the contribution of iron and zinc in the progression of ADHD among children and adolescents, and how therapies including these elements are tolerated along with its effectiveness (according to PRISMA guidelines). Method: The scientific literature was screened for randomized controlled trials published between January 2000 to July 2021. The databases consulted were Medline, PsycINFO, Web of Science, and Google Scholar. Two independent reviewers screened studies, extracted data, and assessed quality and risk of bias (CONSORT, NICE, and Cochrane checklists used). Conclusion: Nine studies met the eligibility criteria and were selected. Evidence was obtained regarding the contribution of iron-zinc supplementation in the treatment of ADHD among young individuals. The discussion was focused on how the deficits of these elements contribute to affectation on multiple ADHD correlates, and potential mechanisms explaining the mediational pathways. Evidence also suggested that treating ADHD with diet interventions might be particularly useful for specific subgroups of children and adolescents, but further investigations of the effects of these diet interventions are needed.Roser GraneroAlfred Pardo-GarridoIvonne Lorena Carpio-ToroAndrés Alexis Ramírez-CoronelPedro Carlos Martínez-SuárezGeovanny Genaro Reivan-OrtizMDPI AGarticleADHDzincirontreatmentchildrenNutrition. Foods and food supplyTX341-641ENNutrients, Vol 13, Iss 4059, p 4059 (2021)
institution DOAJ
collection DOAJ
language EN
topic ADHD
zinc
iron
treatment
children
Nutrition. Foods and food supply
TX341-641
spellingShingle ADHD
zinc
iron
treatment
children
Nutrition. Foods and food supply
TX341-641
Roser Granero
Alfred Pardo-Garrido
Ivonne Lorena Carpio-Toro
Andrés Alexis Ramírez-Coronel
Pedro Carlos Martínez-Suárez
Geovanny Genaro Reivan-Ortiz
The Role of Iron and Zinc in the Treatment of ADHD among Children and Adolescents: A Systematic Review of Randomized Clinical Trials
description Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder common from childhood to adulthood, affecting 5% to 12% among the general population in developed countries. Potential etiological factors have been identified, including genetic causes, environmental elements and epigenetic components. Nutrition is currently considered an influencing factor, and several studies have explored the contribution of restriction and dietary supplements in ADHD treatments. Iron is an essential cofactor required for a number of functions, such as transport of oxygen, immune function, cellular respiration, neurotransmitter metabolism (dopamine production), and DNA synthesis. Zinc is also an essential trace element, required for cellular functions related to the metabolism of neurotransmitters, melatonin, and prostaglandins. Epidemiological studies have found that iron and zinc deficiencies are common nutritional deficits worldwide, with important roles on neurologic functions (poor memory, inattentiveness, and impulsiveness), finicky appetite, and mood changes (sadness and irritability). Altered levels of iron and zinc have been related with the aggravation and progression of ADHD. Objective: This is a systematic review focused on the contribution of iron and zinc in the progression of ADHD among children and adolescents, and how therapies including these elements are tolerated along with its effectiveness (according to PRISMA guidelines). Method: The scientific literature was screened for randomized controlled trials published between January 2000 to July 2021. The databases consulted were Medline, PsycINFO, Web of Science, and Google Scholar. Two independent reviewers screened studies, extracted data, and assessed quality and risk of bias (CONSORT, NICE, and Cochrane checklists used). Conclusion: Nine studies met the eligibility criteria and were selected. Evidence was obtained regarding the contribution of iron-zinc supplementation in the treatment of ADHD among young individuals. The discussion was focused on how the deficits of these elements contribute to affectation on multiple ADHD correlates, and potential mechanisms explaining the mediational pathways. Evidence also suggested that treating ADHD with diet interventions might be particularly useful for specific subgroups of children and adolescents, but further investigations of the effects of these diet interventions are needed.
format article
author Roser Granero
Alfred Pardo-Garrido
Ivonne Lorena Carpio-Toro
Andrés Alexis Ramírez-Coronel
Pedro Carlos Martínez-Suárez
Geovanny Genaro Reivan-Ortiz
author_facet Roser Granero
Alfred Pardo-Garrido
Ivonne Lorena Carpio-Toro
Andrés Alexis Ramírez-Coronel
Pedro Carlos Martínez-Suárez
Geovanny Genaro Reivan-Ortiz
author_sort Roser Granero
title The Role of Iron and Zinc in the Treatment of ADHD among Children and Adolescents: A Systematic Review of Randomized Clinical Trials
title_short The Role of Iron and Zinc in the Treatment of ADHD among Children and Adolescents: A Systematic Review of Randomized Clinical Trials
title_full The Role of Iron and Zinc in the Treatment of ADHD among Children and Adolescents: A Systematic Review of Randomized Clinical Trials
title_fullStr The Role of Iron and Zinc in the Treatment of ADHD among Children and Adolescents: A Systematic Review of Randomized Clinical Trials
title_full_unstemmed The Role of Iron and Zinc in the Treatment of ADHD among Children and Adolescents: A Systematic Review of Randomized Clinical Trials
title_sort role of iron and zinc in the treatment of adhd among children and adolescents: a systematic review of randomized clinical trials
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/b888a072aa5e422a8f50aacf88d99d81
work_keys_str_mv AT rosergranero theroleofironandzincinthetreatmentofadhdamongchildrenandadolescentsasystematicreviewofrandomizedclinicaltrials
AT alfredpardogarrido theroleofironandzincinthetreatmentofadhdamongchildrenandadolescentsasystematicreviewofrandomizedclinicaltrials
AT ivonnelorenacarpiotoro theroleofironandzincinthetreatmentofadhdamongchildrenandadolescentsasystematicreviewofrandomizedclinicaltrials
AT andresalexisramirezcoronel theroleofironandzincinthetreatmentofadhdamongchildrenandadolescentsasystematicreviewofrandomizedclinicaltrials
AT pedrocarlosmartinezsuarez theroleofironandzincinthetreatmentofadhdamongchildrenandadolescentsasystematicreviewofrandomizedclinicaltrials
AT geovannygenaroreivanortiz theroleofironandzincinthetreatmentofadhdamongchildrenandadolescentsasystematicreviewofrandomizedclinicaltrials
AT rosergranero roleofironandzincinthetreatmentofadhdamongchildrenandadolescentsasystematicreviewofrandomizedclinicaltrials
AT alfredpardogarrido roleofironandzincinthetreatmentofadhdamongchildrenandadolescentsasystematicreviewofrandomizedclinicaltrials
AT ivonnelorenacarpiotoro roleofironandzincinthetreatmentofadhdamongchildrenandadolescentsasystematicreviewofrandomizedclinicaltrials
AT andresalexisramirezcoronel roleofironandzincinthetreatmentofadhdamongchildrenandadolescentsasystematicreviewofrandomizedclinicaltrials
AT pedrocarlosmartinezsuarez roleofironandzincinthetreatmentofadhdamongchildrenandadolescentsasystematicreviewofrandomizedclinicaltrials
AT geovannygenaroreivanortiz roleofironandzincinthetreatmentofadhdamongchildrenandadolescentsasystematicreviewofrandomizedclinicaltrials
_version_ 1718410916481990656